Cargando…

Anti-carbamylated protein antibodies in systemic sclerosis

BACKGROUND: To investigate the presence of different isotypes of anti-carbamylated protein (CarP) antibodies in systemic sclerosis (SSc) patients and its association with skin involvement. METHODS: Sera of 194 SSc patients from the Leiden CCISS cohort, fulfilling ACR/EULAR 2013 criteria and a clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liem, Sophie I. E., Hoekstra, E. M., Levarht, E. W. Nivine, Dorjee, Annemarie L., Scherer, Hans U., Toes, René E. M., Huizinga, Tom W. J., de Vries-Bouwstra, Jeska K., Fehres, Cynthia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360323/ https://www.ncbi.nlm.nih.gov/pubmed/37480150 http://dx.doi.org/10.1186/s13075-023-03099-3

Ejemplares similares

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies
por: Liem, Sophie I E, et al.
Publicado: (2023)

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis
por: Wortel, Corrie M, et al.
Publicado: (2023)

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
por: Shi, Jing, et al.
Publicado: (2015)

Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants
por: van Leeuwen, Nina M, et al.
Publicado: (2021)

Rituximab in early systemic sclerosis
por: Boonstra, Maaike, et al.
Publicado: (2017)

Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis
por: van Leeuwen, Nina M., et al.
Publicado: (2021)

The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial
por: Liem, Sophie I E, et al.
Publicado: (2022)

Disease progression in systemic sclerosis
por: van Leeuwen, Nina M, et al.
Publicado: (2021)

The effect and safety of exercise therapy in patients with systemic sclerosis: a systematic review
por: Liem, Sophie I E, et al.
Publicado: (2019)

Antibodies Specific for Carbamylated Proteins Precede the Onset of Clinical Symptoms in Mice with Collagen Induced Arthritis
por: Stoop, Jeroen N., et al.
Publicado: (2014)

Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity
por: Teng, YK Onno, et al.
Publicado: (2012)

The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA
por: Suwannalai, Parawee, et al.
Publicado: (2011)

Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis
por: Habets, Kim L.L., et al.
Publicado: (2015)

Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis
por: Boonstra, Maaike, et al.
Publicado: (2020)

Contribution of Sex and Autoantibodies to Microangiopathy Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: A Systematic Review of the Literature
por: van Leeuwen, Nina M., et al.
Publicado: (2021)

Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group study
por: van Leeuwen, Nina M., et al.
Publicado: (2020)

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients
por: van Delft, Myrthe A. M., et al.
Publicado: (2017)

The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis
por: Liem, Sophie IE, et al.
Publicado: (2023)

Anti‐C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single‐centre, cross‐sectional study
por: Dijkstra, D.J., et al.
Publicado: (2021)

Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis
por: Verheul, Marije K., et al.
Publicado: (2017)

New risk model is able to identify patients with a low risk of progression in systemic sclerosis
por: van Leeuwen, Nina Marijn, et al.
Publicado: (2021)

Retraction Note: Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium
por: Suurmond, Jolien, et al.
Publicado: (2015)

A prediction model for progressive disease in systemic sclerosis
por: Meijs, Jessica, et al.
Publicado: (2015)

Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients
por: Chadli, Loubna, et al.
Publicado: (2019)

Gastrointestinal symptom severity and progression in systemic sclerosis
por: van Leeuwen, Nina M, et al.
Publicado: (2022)

Whole body insulin sensitivity is increased in systemic sclerosis
por: Ciaffi, Jacopo, et al.
Publicado: (2023)

Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide
por: Ciaffi, Jacopo, et al.
Publicado: (2022)

Autoimmune Responses in the Rheumatoid Synovium
por: Toes, Rene E. M, et al.
Publicado: (2009)

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load
por: Reijm, Sanne, et al.
Publicado: (2021)

Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis
por: Meijs, Jessica, et al.
Publicado: (2016)

Comparison of homocitrulline and carbamylated albumin as biomarkers of carbamylation reactions in hemodialyzed patients
por: Lenglet, Aurelie, et al.
Publicado: (2023)

Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium
por: Suurmond, Jolien, et al.
Publicado: (2011)

Role of Anti–Carbamylated Protein Antibodies Compared to Anti–Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First‐Degree Relatives, and Healthy Controls
por: Koppejan, H., et al.
Publicado: (2016)

OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis
por: Takata, Miki, et al.
Publicado: (2019)

Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort
por: Liem, Sophie I E, et al.
Publicado: (2023)

Pulmonary veno-occlusive disease in a patient with recently diagnosed systemic sclerosis
por: van Leeuwen, Nina M, et al.
Publicado: (2019)

Protein Carbamylation and Cardiovascular Disease
por: Verbrugge, Frederik H., et al.
Publicado: (2015)

Exploring the effects of a combined exercise programme on pain and fatigue outcomes in people with systemic sclerosis: study protocol for a large European multi-centre randomised controlled trial
por: Mitropoulos, Alexandros, et al.
Publicado: (2022)

Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies
por: Nakabo, Shuichiro, et al.
Publicado: (2017)

Carbamylated lipoproteins in diabetes
por: Denimal, Damien
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vk3c5bee58fmonb6mq6pbu6b3a